Observation on the Treg in the Uveitis Patients
NCT01306474 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2011-03-03
Summary
AIM: To study the expression of CD4+CD25+ high regulatory T cells in peripheral blood of patients with uveitis and to explore its role in the development of uveitis.
Conditions
- Uveitis
Sponsors & Collaborators
-
Xijing Hospital
lead OTHER
Principal Investigators
-
li cai, MD · the ophthalmology department, xijing Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2010-08-31
- Completion
- 2010-08-31
Countries
- China
Study Locations
More Related Trials
-
Microbiome as a ThErapeutic Response Biomarker
NCT04721743 ·Status: WITHDRAWN
-
Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases
NCT00357071 ·Status: COMPLETED
-
Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior Uveitis
NCT04798755 ·Status: UNKNOWN ·Phase: PHASE3
-
Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X)
NCT02375685 ·Status: TERMINATED ·Phase: PHASE3
-
Use of Thalidomide in Chronic Uveitis
NCT00314665 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation and Treatment of Patients With Inflammatory Eye Diseases
NCT00006188 ·Status: COMPLETED
-
ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)
NCT02931175 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial of Infliximab for Uveitis
NCT00273390 ·Status: COMPLETED ·Phase: NA
-
Outcome of Treatment of Uveitis With Biologic Drugs in Resistant Cases Vogt-koyanagi-Harada Disease
NCT05349747 ·Status: UNKNOWN
-
Methotrexate and Mycophenolate Mofetil for UVEITIS
NCT01829295 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis
NCT01327664 ·Status: WITHDRAWN ·Phase: PHASE3
-
Multicenter Clinical Study of Anti-VEGF Treatment on High Risk Diabetic Retinopathy (DR)
NCT03452657 ·Status: UNKNOWN ·Phase: PHASE3
-
Biomarkers in Ocular Inflammation and Uveitis
NCT04690829 ·Status: COMPLETED
-
Phase 2 Study of MM-093 to Treat Patients With Uveitis
NCT00444743 ·Status: COMPLETED ·Phase: PHASE2
-
Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis
NCT00043667 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
NCT03066869 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate
NCT01314417 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Adalimumab in Patients With Active Uveitis
NCT01138657 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of AIN457 in Noninfectious Uveitis
NCT00685399 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis
NCT05105347 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Treatment -Resistant Neovascular Age-Related Macular Degeneration
NCT02332941 ·Status: COMPLETED ·Phase: PHASE1
-
Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis
NCT01103024 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis
NCT02258867 ·Status: TERMINATED ·Phase: PHASE3
-
Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments
NCT00976222 ·Status: COMPLETED ·Phase: PHASE4
-
Mycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot Study
NCT01261169 ·Status: UNKNOWN